In formal comments filed with the Internal Revenue Service (“IRS”) this week, the Center for Individual…
CFIF on Twitter CFIF on YouTube
CFIF Files Comments in Support of IRS Rulemaking to Protect Donor Privacy

In formal comments filed with the Internal Revenue Service (“IRS”) this week, the Center for Individual Freedom (“CFIF”) offered strong support for the IRS’s proposed rulemaking to eliminate the requirement that certain nonprofit organizations provide the names and addresses of contributors on Schedule B of their annual tax filings.

As CFIF notes in its filing, "the Proposed Rulemaking would help protect the First Amendment rights of subject organizations and their citizen donors, without negatively impacting the legally permissible handling of the nation’s tax laws or 501(c) organization tax filings."

Read CFIF’s comments here (PDF).…[more]

December 11, 2019 • 03:45 pm

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Press Releases
CFIF Urges “No” Vote on H.R. 3, Speaker Pelosi’s Destructive Drug Pricing Bill Print E-mail
Wednesday, December 11 2019

ALEXANDRIA, VA – The U.S. House of Representatives is scheduled to vote on Speaker Nancy Pelosi's H.R. 3, the "Lower Drug Costs Now Act of 2019."  The Center for Individual Freedom ("CFIF") is urging all House Members to vote "No," as the legislation would, among other significant issues, stifle innovation, limit access to life-saving medications and reduce projected gains in life-expectancy for all Americans. What follows is a statement by CFIF President Jeffrey Mazzella:

"CFIF unambiguously opposes H.R. 3, the so-called 'Lower Drug Costs Now Act of 2019'.

"Contrary to its misleading title, the primary effect of Pelosi’s bill wouldn’t be to lower drug costs, but to severely threaten Americans’ access to healthcare and life-saving medicines by imposing foreign price controls, compulsory arbitration with government bureaucrats, a complete restructuring of the popular Medicare Part D program and what amounts to a retroactive tax on hundreds of the most commonly used medicines in America.

"America currently claims the world’s most innovative pharmaceutical industry, accounting for two-thirds of all new lifesaving and life-improving drugs globally.  But by importing price controls from foreign nations – which ignore drug patents to extort compliance – American consumers would suffer the same negative consequences that those nations’ consumers do:  unavailability of those critical lifesaving and life-improving drugs.

"Indeed, the Congressional Budget Office ('CBO') itself determined that H.R. 3 would reduce the number of new medicines introduced into the market, and the Council of Economic Advisers (‘CEA’) found that the bill’s price control mechanisms would impact fully one-third of all medicines under development.  The CEA also forecasts that H.R. 3 would reduce current expected U.S. life expectancy improvements over the coming decade by 25%.

"The United Nations World Health Organization ('WHO') has similarly acknowledged that price controls suffocate innovation and delay the arrival of new drugs, or deny them entirely.  That's why the nations pursuing that destructive path receive a mere fraction of the new pharmaceuticals that Americans are able to access, which also explains why America outpaces those countries in terms of cancer survival rates and other benefits.  Pelosi's bill would also jeopardize nearly $1 trillion of pharmaceutical investment, research and development.

"This is all far too high a price for Americans to pay on behalf of Nancy Pelosi's big-government drug pricing scheme. CFIF therefore opposes H.R. 3 in the strongest terms, applauds Members of Congress who have already voiced opposition to it and urges all House Members to vote 'No.'"

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide. 

###

 


Page 1 of 203
Question of the Week   
The most recent U.S. Senator to be elected President of the United States was Barack Obama. Who was the first U.S. Senator to be elected President?
More Questions
Quote of the Day   
 
"Gobsmacked Republicans made known their fury and frustration late Thursday as House Judiciary Committee Chairman Jerry Nadler, D-N.Y., abruptly wrapped up an all-day marathon hearing on the adoption of two articles of impeachment against President Trump by delaying planned votes on the matter until Friday morning.'It is now very late at night,' Nadler said shortly before midnight in D.C. 'I want…[more]
 
 
—Gregg Re, FOX News
— Gregg Re, FOX News
 
Liberty Poll   

Which of the following is the most important political event of the week?